Adicet Bio Reveals Executive Compensation Details
Ticker: ACET · Form: DEF 14A · Filed: Apr 29, 2025 · CIK: 1720580
| Field | Detail |
|---|---|
| Company | Adicet Bio, Inc. (ACET) |
| Form Type | DEF 14A |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, equity-awards, sec-filing
TL;DR
Adicet Bio's DEF 14A shows exec comp details for 2024, including equity awards.
AI Summary
Adicet Bio, Inc. filed a DEF 14A on April 29, 2025, detailing executive compensation and equity awards. For the fiscal year ending December 31, 2024, the company reported equity awards granted to non-principal executive officers (Non-PEO) and principal executive officers (PEO). Specific details on the fair value of these awards, changes in fair value, and outstanding unvested awards are provided for the fiscal years 2022, 2023, and 2024.
Why It Matters
This filing provides transparency into how Adicet Bio compensates its top executives and employees, which can influence investor perception and employee retention.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of executive compensation and does not present new material risks.
Key Numbers
- 2024 — Fiscal Year (Reporting period for equity awards and fair value changes.)
- 2023 — Fiscal Year (Reporting period for equity awards and fair value changes.)
- 2022 — Fiscal Year (Reporting period for equity awards and fair value changes.)
Key Players & Entities
- Adicet Bio, Inc. (company) — Filer
- Nick Harvey (person) — Mentioned in relation to equity awards
- resTORbio, Inc. (company) — Former company name
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing is used to solicit proxies from shareholders for an annual or special meeting of shareholders, and it provides detailed information about executive compensation, board of directors, and other corporate governance matters.
When was Adicet Bio, Inc. formerly known as?
Adicet Bio, Inc. was formerly known as resTORbio, Inc., with a date of name change on October 24, 2017.
What type of compensation details are provided in this filing?
This filing provides details on equity awards, including their fair value, changes in fair value, and outstanding unvested awards for both PEO (Principal Executive Officer) and Non-PEO (Non-Principal Executive Officer) members for fiscal years 2022, 2023, and 2024.
What is the SIC code for Adicet Bio, Inc.?
The Standard Industrial Classification (SIC) code for Adicet Bio, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the business address of Adicet Bio, Inc.?
The business address of Adicet Bio, Inc. is 131 Dartmouth Street, 3rd Floor, Boston, MA 02116.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 29, 2025 by Nick Harvey regarding Adicet Bio, Inc. (ACET).